查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
药品监管事务市场，按服务、按类别、按产品阶段、按适应症、服务提供者、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1419028

药品监管事务市场，按服务、按类别、按产品阶段、按适应症、服务提供者、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Pharmaceutical Regulatory Affairs Market, By Services, By Category, By Product stage, By Indication, Service Provider, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 277 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年药品监管事务市场规模为138.154亿美元，2023年至2030年复合CAGR为8.5%。

药品监理事务市场-市场动态

製药和生物技术行业的扩张以及对药物开发的日益重视预计将推动药品监管事务市场的成长。

製药公司正在积极寻求全球市场扩张。为了进入新市场，他们必须遵守不同国家的各种监管要求。监管事务专业人员的角色对于应对这些复杂的监管环境、确保产品符合必要的标准并获得销售批准至关重要。根据医药统计，2021年美国医药产业收入达5,500亿美元。此外，美国人同年在药品上的支出为5,769亿美元。对药物发现和开发的日益关注导致向监管机构提交的新药申请和提交数量增加。目前，市场上有超过 40,000 种 FDA 批准的药物。对细胞和基因疗法等先进疗法以及个人化医疗的日益重视，为监管事务市场带来了机会。然而，值得注意的是，严格的监管要求可能会带来挑战并限制市场的成长。

药品监管事务市场-关键见解

  • 根据我们的研究分析师分享的分析，预计全球市场在预测期内（2023-2030 年）每年将以 8.5% 左右的CAGR成长
  • 根据服务细分，监管写作和出版预计将在 2022 年显示最大的市场份额
  • 从品类细分来看，2022年药品为主导品类
  • 依产品阶段划分，2022年临床研究为主导类型
  • 根据适应症细分，肿瘤学是2022年的主导类型
  • 根据服务提供者细分，外包是 2022 年的主导类型
  • 按地区划分，北美是 2022 年的主要收入来源

药品监理事务市场-細項分析：

全球药品监管事务市场根据服务、类别、产品阶段、适应症、服务提供者和地区进行细分。

市场根据服务分为五类：监管咨询、法律代表、监管写作和出版（写作、出版）、产品註册和临床试验类别以及其他服务。监管写作和出版在市场上占有重要地位。它在监管事务中发挥着至关重要的作用，包括准备、彙编和提交产品批准和上市后活动所需的各种监管文件。监管撰写者的责任是将复杂的科学和临床资料转化为符合监管标准的结构良好且全面的文件。另一方面，监管发布涉及对这些文件进行格式化、组织以及以指定的电子格式向卫生当局提交。

市场依类别分为两类：药物和生物製剂。药品细分市场占据主导地位。药品监管事务部门在药品上市过程中扮演至关重要的角色。它涉及透过监管途径、确保遵守法规以及促进与卫生当局的有效沟通。这确保了药物的开发和销售方式优先考虑患者的安全性和有效性。

根据产品阶段，市场分为三类：临床前、临床研究和 PMA。市场主要由临床研究领域主导。监管专业人员在确保临床试验符合监管标准方面发挥着至关重要的作用，从而促进安全有效的药品的开发。作为临床试验申办者和监管机构之间的中间人，他们在向市场推出新疗法方面发挥关键作用。

市场根据适应症分为四类：肿瘤学、神经学、心臟病学、免疫学和其他。肿瘤学领域主导市场。监管事务专家与肿瘤药物开发团队密切合作，制定监管策略，以解决癌症治疗开发中遇到的独特障碍。肿瘤药物有可能获得快速通道、突破性治疗或孤儿药等特殊称号。监管事务专业人员在获得这些指定以加速开发和监管程序方面发挥着至关重要的作用。

市场根据服务提供者分为两类：内部和外包。该市场主要由外包领域主导。在这一领域，外包公司负责管理监管文件的编制、格式化和向卫生当局的提交。此外，公司可以选择外包监管流程中新技术的实施，例如电子提交工具或人工智慧应用程式。

药品监理事务市场-地理洞察

该市场在地理上广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些区域根据参与商业活动的国家进一步划分。亚太地区预计将引领市场成长，这主要是由于其对先进疗法和个人化医疗的日益关注。该地区非常重视生物製剂、基因疗法和个人化医疗等先进疗法。监管事务专业人员在促进这些创新疗法的开发、註册和市场准入方面发挥着至关重要的作用，从而促进了监管事务市场的整体成长。中国拥有超过14亿人口，面临开发新疗法特别是基因疗法的迫切需求，因为中国估计有5,700万名遗传疾病患者，每年新增癌症病例超过400万例。在预测期内，由于欧洲和北美地区进行的临床试验数量不断增加，以及涉足这些地区的生物製药公司不断增加，预计这些地区也将推动市场成长。

药品监理事务市场-竞争格局：

製药业是一个不断发展和研究驱动的行业，深受一系列复杂法规的影响。这些法规旨在促进药物设计和生产的研究和创新，保护消费者免受药物造成的潜在伤害，并规范公共和私营部门的药物支出。然而，实现这些目标有时会产生衝突，需要在生产者和消费者的利益之间进行仔细的平衡。为了因应这一监管环境，专业顾问公司、合约研究组织 (CRO) 和製药公司的内部部门提供监管事务服务。这些服务提供了一种经济高效且便捷的选择，可以为消费者组织团队提供必要的工具和知识，使其成为监管专业人士并在竞争中保持领先地位。在这个市场中，竞争可能会以开发和采用简化监管合规流程的技术的形式出现，例如监管资讯管理系统（RIMS）和电子提交工具。

最近的发展：

2023 年 9 月，全球领先的监管解决方案和服务供应商 Freyr Solutions 很高兴地宣布与 PKG Group LLC 建立策略伙伴关係。此次合作已成功向美国食品药物管理局 (US FDA) 提交 PKG 集团的 III 类药物主文件 (DMF)。 Freyr 为 III 类 DMF 註册支援提供了全面的服务，包括对文件的全面分析、eCTD 格式檔案的彙编以及整个提交过程中的专家指导。此外，Freyr 还提供了管理美国 FDA 查询的协助，确保了无缝且高效的提交流程。

目录

第一章：药品监理事务市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 药品监理事务市场片段（按服务）
    • 按类别分類的药品监管事务市场片段
    • 按产品阶段分類的药品监理事务市场片段
    • 按适应症分類的药品监管事务市场片段
    • 服务提供者的药品监管事务市场片段
    • 按国家/地区分類的药品监管事务市场片段
    • 按地区分類的药品监管事务市场片段
  • 竞争洞察

第 3 章：药品监理事务主要市场趋势

  • 药品监管事务市场驱动因素
    • 市场驱动因素的影响分析
  • 药品监理事务市场限制
    • 市场限制影响分析
  • 药品监管事务市场机会
  • 药品监理事务市场未来趋势

第 4 章：药品监管事务产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：药品监理事务市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：药品监理事务市场格局

  • 2022 年药品监理事务市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：药品监理事务市场 - 按服务

  • 概述
    • 按服务分類的细分市场占有率分析
    • 监理咨询
    • 法律代表
    • 监理写作与出版（写作、出版）
    • 产品註册及临床试验服务
    • 其他

第 8 章：药品监理事务市场 - 按类别

  • 概述
    • 按类别分類的细分市场占有率分析
    • 药品
      • 创新者
      • 泛型
      • 生物製剂
      • 生物技术
      • ATMP
      • 生物相似药

第 9 章：药品监理事务市场 - 按产品阶段

  • 概述
    • 细分市场占有率分析，依产品阶段
    • 临床前
    • 临床研究
    • 聚甲基丙烯酸甲酯

第 10 章：药品监理事务市场 - 依适应症分类

  • 概述
    • 按指标分類的细分市场占有率分析
    • 临床前
    • 临床研究
    • 聚甲基丙烯酸甲酯

第 11 章：药品监管事务市场 - 按服务提供者

  • 概述
    • 按服务提供者分類的细分市场份额分析
    • 内部
    • 外包

第 12 章：药品监管事务市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美药品监管事务主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按服务）
    • 北美市场规模和预测（按类别）
    • 北美市场规模与预测，按产品阶段
    • 北美市场规模和预测（按指标）
    • 北美市场规模和预测（按服务提供者）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲药品监管事务主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按服务）
    • 欧洲市场规模和预测（按类别）
    • 欧洲市场规模与预测，依产品阶段
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模和预测（按服务提供者）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区药品监管事务主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按服务）
    • 亚太地区市场规模和预测（按类别）
    • 亚太地区市场规模与预测（依产品阶段）
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模和预测（按服务提供者）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲药品监管事务主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按服务）
    • 拉丁美洲市场规模和预测（按类别）
    • 拉丁美洲市场规模与预测，依产品阶段
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模和预测（按服务提供者）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲药品监管事务主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按服务）
    • 中东和非洲市场规模及预测（按类别）
    • 中东和非洲市场规模及预测（按产品阶段）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模及预测（按服务提供者）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 13 章：主要供应商分析 - 药品监管事务产业

  • 竞争仪表板
  • 公司简介
    • Freyr
    • IQVIA Inc
    • ICON plc
    • WuXi AppTec
    • Charles River Laboratories
    • Labcorp Drug Development
    • Parexel International Corporation
    • Pharmalex GmbH
    • Pharmexon
    • Genpact

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2093

REPORT HIGHLIGHT

Pharmaceutical Regulatory Affairs Market size was valued at USD 13,815.4 Million in 2022, expanding at a CAGR of 8.5% from 2023 to 2030.

Pharmaceutical Regulatory Affairs professionals play a crucial role in ensuring compliance with laws and regulations within the industry. Their main objective is to guarantee the safety, effectiveness, and quality of pharmaceutical products. The pharmaceutical industry is highly regulated, and regulatory affairs professionals are essential in the development of drugs, acting as the primary communication channel between the company and regulatory agencies such as the FDA. They are responsible for staying updated on the ever-expanding and intricate regulatory landscape. In addition to their knowledge of legal and regulatory environments, these professionals also possess expertise in clinical research protocols.

Pharmaceutical Regulatory Affairs Market- Market Dynamics

The growth of the Pharmaceutical Regulatory Affairs market is anticipated to be driven by the expansion of Pharma and Biotech industries, as well as the increasing emphasis on drug development.

Pharmaceutical companies are actively pursuing global expansion of their market presence. In order to enter new markets, they must adhere to various regulatory requirements in different countries. The role of regulatory affairs professionals is vital in navigating these intricate regulatory landscapes, ensuring that products meet the necessary standards and obtain approval for sale. According to Pharmaceutical Statistics, the revenue generated by the U.S. pharmaceutical industry reached USD 550 billion in 2021. Additionally, Americans spent USD 576.9 billion on medicine in the same year. The increasing focus on drug discovery and development has resulted in a higher number of new drug applications and submissions to regulatory agencies. Currently, there are more than 40,000 FDA-approved drugs available in the market. The growing emphasis on advanced therapies, such as cell and gene therapies, along with personalized medicine, presents opportunities for the regulatory affairs market. However, it is important to note that stringent regulatory requirements may pose challenges and restrict the growth of the market.

Pharmaceutical Regulatory Affairs Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2023-2030)
  • Based on Services segmentation, Regulatory Writing & Publishing was predicted to show maximum market share in the year 2022
  • Based on Category segmentation, Drugs was the leading type in 2022
  • Based on Product stage segmentation, Clinical Studies was the leading type in 2022
  • Based on Indication segmentation, Oncology was the leading type in 2022
  • Based on Service providers segmentation, Outsourcing was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Pharmaceutical Regulatory Affairs Market- Segmentation Analysis:

The Global Pharmaceutical Regulatory Affairs Market is segmented on the basis of Services, Category, Product stage, Indication, Service provider and Region.

The market is divided into five categories based on Services: Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing (Writing, Publishing), Product Registration & Clinical Trial Category and Other Services. Regulatory Writing & Publishing holds a significant position in the market. It plays a crucial role in Regulatory Affairs, encompassing the preparation, compilation, and submission of diverse regulatory documents necessary for product approval and post-marketing activities. The responsibility of regulatory writers is to transform intricate scientific and clinical data into well-structured and comprehensive documents that adhere to regulatory standards. On the other hand, regulatory publishing involves the formatting, organizing, and submission of these documents in the specified electronic formats to health authorities.

The market is divided into two categories based on Category: Drugs and Biologics. Drugs segment dominates the market. The The Pharmaceutical Regulatory Affairs sector plays a crucial role in the process of introducing drugs to the market. It involves navigating through regulatory pathways, ensuring adherence to regulations, and facilitating effective communication with health authorities. This ensures that drugs are developed and marketed in a way that prioritizes the safety and effectiveness for patients.

The market is divided into three categories based on Product stage: Preclinical, Clinical Studies and PMA.The market is primarily dominated by the Clinical Studies segment. Regulatory professionals play a crucial role in ensuring that clinical trials comply with regulatory standards, thereby facilitating the creation of pharmaceutical products that are both safe and effective. Acting as intermediaries between clinical trial sponsors and regulatory authorities, they play a pivotal role in the introduction of new therapies to the market.

The market is divided into four categories based on Indication: Oncology, Neurology, Cardiology, Immunology and Others. Oncology segment dominates the market. Regulatory Affairs experts work closely with oncology drug development teams to formulate regulatory strategies that tackle the distinctive obstacles encountered in the development of cancer treatments. Oncology drugs have the potential to receive special designations like Fast Track, Breakthrough Therapy, or Orphan Drug status. Regulatory Affairs professionals play a crucial role in securing these designations to accelerate the development and regulatory procedures.

The market is divided into two categories based on Service Provider: In-house and Outsourcing. The market is primarily dominated by the outsourcing segment. Within this segment, outsourcing firms are responsible for managing the compilation, formatting, and submission of regulatory documents to health authorities. Additionally, companies have the option to outsource the implementation of new technologies in regulatory processes, such as electronic submission tools or artificial intelligence applications.

Pharmaceutical Regulatory Affairs Market- Geographical Insights

This market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The Asia Pacific region is expected to lead the market growth, primarily due to its increasing focus on Advanced Therapies and Personalized Medicine. In this region, there is a significant emphasis on advanced therapies such as biologics, gene therapies, and personalized medicine. Regulatory affairs professionals play a vital role in facilitating the development, registration, and market access of these innovative therapies, thereby contributing to the overall growth of the regulatory affairs market. With a population of over 1.4 billion, China faces an urgent demand for the development of new therapeutics, especially gene therapies, as it has an estimated 57 million people with genetic diseases and over 4 million new cancer cases annually. During forecast period, Europe and North America are also expected to drive market growth due to the increasing number of clinical trials conducted in these regions and the growing presence of biopharmaceutical companies venturing into these areas.

Pharmaceutical Regulatory Affairs Market- Competitive Landscape:

The pharmaceutical industry is a constantly evolving and research-driven sector that is heavily influenced by a complex set of regulations. These regulations aim to foster research and innovation in drug design and production, safeguard consumers from potential harm caused by drugs, and regulate the expenditure on drugs in both public and private sectors. However, achieving these objectives can sometimes create conflicts and necessitate a careful balance between the interests of producers and consumers. To navigate this regulatory landscape, specialized consulting firms, contract research organizations (CROs), and in-house departments of pharmaceutical companies offer regulatory affairs services. These services provide a cost-effective and convenient option for equipping consumer organizational teams with the necessary tools and knowledge to excel as regulatory professionals and stay ahead of the competition. In this market, competition may arise in the form of the development and adoption of technologies that streamline regulatory compliance processes, such as regulatory information management systems (RIMS) and electronic submission tools.

Recent Developments:

On September 2023, Freyr Solutions, the leading global provider of Regulatory solutions and services, is pleased to announce its strategic partnership with PKG Group LLC. This collaboration has resulted in the successful submission of PKG Group's Type III Drug Master File (DMF) to the US Food and Drug Administration (US FDA). Freyr has provided a comprehensive range of services for the Type III DMF registration support, including a thorough analysis of the documents, compilation of the dossier in eCTD format, and expert guidance throughout the submission process. Additionally, Freyr has offered assistance in managing queries from the US FDA, ensuring a seamless and efficient submission process.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET KEY PLAYERS

  • Freyr
  • IQVIA Inc
  • ICON plc
  • WuXi AppTec
  • Charles River Laboratories
  • Labcorp Drug Development
  • Parexel International Corporation
  • Pharmalex GmbH
  • Pharmexon
  • Genpact

GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET, BY SERVICES

  • Regulatory Consulting
  • Legal Representation
  • Regulatory Writing & Publishing (Writing, Publishing)
  • Product Registration & Clinical Trial Categorys
  • Other

GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET, BY CATEGORY

  • Drugs
  • Innovator
  • Generics
  • Biologics
  • Biotech
  • ATMP
  • Biosimilars

GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET, BY PRODUCT STAGE

  • Preclinical
  • Clinical Studies
  • PMA

GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET, BY INDICATION

  • Oncology
  • Neurology
  • Cardiology
  • Immunology
  • Others

GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET, BY SERVICE PROVIDERS

  • In-house
  • Outsourcing

GLOBAL PHARMACEUTICAL REGULATORY AFFAIRS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pharmaceutical Regulatory Affairs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharmaceutical Regulatory Affairs Market Snippet by Service
    • 2.1.2. Pharmaceutical Regulatory Affairs Market Snippet by Category
    • 2.1.3. Pharmaceutical Regulatory Affairs Market Snippet by Product stage
    • 2.1.4. Pharmaceutical Regulatory Affairs Market Snippet by Indication
    • 2.1.5. Pharmaceutical Regulatory Affairs Market Snippet by Service Providers
    • 2.1.6. Pharmaceutical Regulatory Affairs Market Snippet by Country
    • 2.1.7. Pharmaceutical Regulatory Affairs Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharmaceutical Regulatory Affairs Key Market Trends

  • 3.1. Pharmaceutical Regulatory Affairs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharmaceutical Regulatory Affairs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharmaceutical Regulatory Affairs Market Opportunities
  • 3.4. Pharmaceutical Regulatory Affairs Market Future Trends

4. Pharmaceutical Regulatory Affairs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharmaceutical Regulatory Affairs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pharmaceutical Regulatory Affairs Market Landscape

  • 6.1. Pharmaceutical Regulatory Affairs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharmaceutical Regulatory Affairs Market - By Service

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Service, 2022 & 2030 (%)
    • 7.1.2. Regulatory Consulting
    • 7.1.3. Legal Representation
    • 7.1.4. Regulatory Writing & Publishing (Writing, Publishing)
    • 7.1.5. Product Registration & Clinical Trial services
    • 7.1.6. Other

8. Pharmaceutical Regulatory Affairs Market - By Category

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Category, 2022 & 2030 (%)
    • 8.1.2. Drugs
      • 8.1.2.1. Innovator
      • 8.1.2.2. Generics
      • 8.1.2.3. Biologics
      • 8.1.2.4. Biotech
      • 8.1.2.5. ATMP
      • 8.1.2.6. Biosimilars

9. Pharmaceutical Regulatory Affairs Market - By Product stage

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product stage, 2022 & 2030 (%)
    • 9.1.2. Preclinical
    • 9.1.3. Clinical Studies
    • 9.1.4. PMA

10. Pharmaceutical Regulatory Affairs Market - By Indication

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 10.1.2. Preclinical
    • 10.1.3. Clinical Studies
    • 10.1.4. PMA

11. Pharmaceutical Regulatory Affairs Market - By Service Providers

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Service Providers, 2022 & 2030 (%)
    • 11.1.2. In-house
    • 11.1.3. Outsourcing

12. Pharmaceutical Regulatory Affairs Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Pharmaceutical Regulatory Affairs Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Pharmaceutical Regulatory Affairs Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Pharmaceutical Regulatory Affairs Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Pharmaceutical Regulatory Affairs Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Pharmaceutical Regulatory Affairs Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Category, 2018 - 2030 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Product stage, 2018 - 2030 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Service Providers, 2018 - 2030 (US$ Million)

13. Key Vendor Analysis- Pharmaceutical Regulatory Affairs Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Freyr
    • 13.2.2. IQVIA Inc
    • 13.2.3. ICON plc
    • 13.2.4. WuXi AppTec
    • 13.2.5. Charles River Laboratories
    • 13.2.6. Labcorp Drug Development
    • 13.2.7. Parexel International Corporation
    • 13.2.8. Pharmalex GmbH
    • 13.2.9. Pharmexon
    • 13.2.10. Genpact

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Pharmaceutical Regulatory Affairs Market: Service Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Service
  • TABLE Global Pharmaceutical Regulatory Affairs Market, by Service 2018-2030 (USD Million)
  • TABLE Pharmaceutical Regulatory Affairs Market: Category Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Category
  • TABLE Global Pharmaceutical Regulatory Affairs Market, by Category 2018-2030 (USD Million)
  • TABLE Pharmaceutical Regulatory Affairs Market: Product stage Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product stage
  • TABLE Global Pharmaceutical Regulatory Affairs Market, by Product stage 2018-2030 (USD Million)
  • TABLE Pharmaceutical Regulatory Affairs Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Pharmaceutical Regulatory Affairs Market, by Indication 2018-2030 (USD Million)
  • TABLE Pharmaceutical Regulatory Affairs Market: Service Providers Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Service Providers
  • TABLE Global Pharmaceutical Regulatory Affairs Market, by Service Providers 2018-2030 (USD Million)
  • TABLE Pharmaceutical Regulatory Affairs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Pharmaceutical Regulatory Affairs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Pharmaceutical Regulatory Affairs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Pharmaceutical Regulatory Affairs Market, by Service, 2018-2030 (USD Million)
  • TABLE North America Pharmaceutical Regulatory Affairs Market, by Category, 2018-2030 (USD Million)
  • TABLE North America Pharmaceutical Regulatory Affairs Market, by Product stage, 2018-2030 (USD Million)
  • TABLE North America Pharmaceutical Regulatory Affairs Market, by Indication, 2018-2030 (USD Million)
  • TABLE North America Pharmaceutical Regulatory Affairs Market, by Service Providers, 2018-2030 (USD Million)
  • TABLE Europe Pharmaceutical Regulatory Affairs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Pharmaceutical Regulatory Affairs Market, by Service, 2018-2030 (USD Million)
  • TABLE Europe Pharmaceutical Regulatory Affairs Market, by Category, 2018-2030 (USD Million)
  • TABLE Europe Pharmaceutical Regulatory Affairs Market, by Product stage, 2018-2030 (USD Million)
  • TABLE Europe Pharmaceutical Regulatory Affairs Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Pharmaceutical Regulatory Affairs Market, by Service Providers, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharmaceutical Regulatory Affairs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharmaceutical Regulatory Affairs Market, by Service, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharmaceutical Regulatory Affairs Market, by Category, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharmaceutical Regulatory Affairs Market, by Product stage, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharmaceutical Regulatory Affairs Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharmaceutical Regulatory Affairs Market, by Service Providers, 2018-2030 (USD Million)
  • TABLE Latin America Pharmaceutical Regulatory Affairs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Pharmaceutical Regulatory Affairs Market, by Service, 2018-2030 (USD Million)
  • TABLE Latin America Pharmaceutical Regulatory Affairs Market, by Category, 2018-2030 (USD Million)
  • TABLE Latin America Pharmaceutical Regulatory Affairs Market, by Product stage, 2018-2030 (USD Million)
  • TABLE Latin America Pharmaceutical Regulatory Affairs Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Pharmaceutical Regulatory Affairs Market, by Service Providers, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharmaceutical Regulatory Affairs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharmaceutical Regulatory Affairs Market, by Service, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharmaceutical Regulatory Affairs Market, by Category, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharmaceutical Regulatory Affairs Market, by Product stage, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharmaceutical Regulatory Affairs Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharmaceutical Regulatory Affairs Market, by Service Providers, 2018-2030 (USD Million)